The SSAI fully supports the suspension of hydroxyethyl-starch solutions commissioned by the European Medicines Agency
- PMID: 29658984
- PMCID: PMC6690069
- DOI: 10.1111/aas.13120
The SSAI fully supports the suspension of hydroxyethyl-starch solutions commissioned by the European Medicines Agency
Conflict of interest statement
None.
Comment in
-
Hydroxyethyl starch: A half-century enigma.Acta Anaesthesiol Scand. 2019 Jan;63(1):128-130. doi: 10.1111/aas.13257. Epub 2018 Sep 10. Acta Anaesthesiol Scand. 2019. PMID: 30203538 No abstract available.
References
-
- European Medicines Agency . Hydroxyethyl‐starch solutions for infusion to be suspended – CMDh endorses PRAC recommendation. 2018. [www document] http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2.... Accessed March 18, 2018.
-
- Group FsiftSCCT . Preferences for colloid use in Scandinavian intensive care units. Acta Anaesthesiol Scand. 2008;52:750‐8. - PubMed
-
- Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367:124‐34. - PubMed
-
- Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901‐11. - PubMed
-
- Zarychanski R, Abou‐Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta‐analysis. JAMA. 2013;309:678‐88. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
